FATAL CURE

Gene therapy takes a deadly turn in Rogers’ medical thriller.

In this fourth installment of the author’s Mayfield-Napolitani thriller series, Joe Mayfield and his wife Louise “Weezy” Napolitani hope to land a new client for CyberSol, their cybersecurity company: the Swiss firm APX, a supplier of materials used in gene sequencing. APX recently acquired Gerontin Therapeutics, a start-up that developed a rapid infusion method that can help fix “bad genes in otherwise healthy people.” Former Gerontin scientist Ella Sonesgard, now an APX VP, tells Joe that former employee Daniel Manly and some of Gerontin’s intellectual property have gone missing. But when Joe and Weezy travel from their Bethesda office to meet with Ella in Boston, the cybersleuths are told she is unavailable; instead, company CEO Vic Neuchtermeier, whose shoulders “spoke to hours on the weight bench,” meets with the pair to close out the project, explaining that finding the missing employee and intellectual property is not a priority. However, as they have already surmised that Daniel is in Boston (and because Weezy’s family lives there), the couple remain in Bean Town. They learn from Weezy’s brother that a neighborhood friend, a congressman fighting higher drug prices, has died suddenly of a rare disease. About the same time, a U.S. senator collapsed and died, possibly as a result of recently received prophylactic gene therapy. When Ella is diagnosed with hemophilia, it appears gene therapy has been weaponized. Readers familiar with the series will enjoy this fast-paced entry; newcomers, however, may be puzzled when pieces of backstory are blurted out and wonder if the message-receiving aural implants and other futuristic gizmos in the story were explained thoroughly in previous books—their existence is assumed here. The characters’ relationships and dialogue—particularly between Joe and Weezy—are realistic, playful, and sexy. Humor snakes throughout the narrative, and the descriptions are inventive, such as the image of Weezy’s male relatives being “built like boxes with legs.” The book is topical, with large portions addressing gene therapy and climate change and its deniers, and the ending is killer.

A thrilling jump into the deep end of the (gene) pool.